Financial Archives -

CureVac claims €75m in EU funding for mRNA COVID-19 vaccine

https://pharmaphorum.com/news/curevac-claims-e75m-in-eu-funding-for-mrna-covid-19-vaccine/

Royalty Pharma shares surge 59% after $2.2 billion IPO

https://pharmaphorum.com/news/royalty-pharma-shares-surge-59-after-2-2-billion-ipo/

Celgene investors’ CVR payment looks rocky, as FDA rejects ide-cel file

https://pharmaphorum.com/news/celgene-investors-merger-payment-looks-rocky-as-fda-rejects-ide-cel-file/

COVID-19 candidate Actemra helps Roche to solid first quarter

https://pharmaphorum.com/news/covid-19-candidate-actemra-helps-roche-to-solid-first-quarter/

Bill Gates slams Trump move to cut WHO funding over coronavirus

https://pharmaphorum.com/news/bill-gates-slams-trump-move-to-cut-who-funding-over-coronavirus/

J&J lowers 2020 forecast on COVID-19 uncertainty

https://pharmaphorum.com/news/jj-lowers-2020-forecast-on-covid-19-uncertainty/

Takeda eyes emerging markets asset sale to trim its debt; report

https://pharmaphorum.com/news/takeda-eyes-emerging-markets-asset-sale-to-trim-its-debt-report/

AZ sells US, EU and Latin America rights to gout drug

https://pharmaphorum.com/news/az-sells-us-eu-and-latin-america-rights-to-gout-drug/

NICE and Highly Specialised Technologies: three years on

https://pharmaphorum.com/views-and-analysis/nice-and-highly-specialised-technologies-three-years-on/

Search